New market study, "Organogenesis, Inc. - Product Pipeline Analysis, 2016 Update", has been published

From: Fast Market Research, Inc.
Published: Fri May 06 2016

Organogenesis, Inc. (Organogenesis) is a regenerative medicine company that concentrates on bioactive wound healing and soft tissue regeneration. The company's products include Apligraf and Dermagraft. Its Dermagraft is used for the treatment of full-thickness diabetic foot ulcers which are greater than 6 weeks duration. Organogenesis's Apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers. Its Dermagraft is indicated in conjunction with standard wound care regimens in patients with adequate blood supply to the involved foot. The company serves the areas of bio-active wound healing, oral regeneration and bio-surgery. Organogenesis is headquartered in Canton, Massachusetts, the US.

Full Report Details at

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Organogenesis, Inc.
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2016 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2016 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2016 Update
- Thermo Fisher Scientific Inc. (TMO) - Product Pipeline Analysis, 2016 Update
- Philips Healthcare - Product Pipeline Analysis, 2016 Update

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »